Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис:
http://hdl.handle.net/20.500.12188/9446
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chan, Arlene | en_US |
dc.contributor.author | Moy, Beverly | en_US |
dc.contributor.author | Mansi, Janine | en_US |
dc.contributor.author | Ejlertsen, Bent | en_US |
dc.contributor.author | Holmes, Frankie Ann | en_US |
dc.contributor.author | Chia, Stephen | en_US |
dc.contributor.author | Iwata, Hiroji | en_US |
dc.contributor.author | Gnant, Michael | en_US |
dc.contributor.author | Loibl, Sibylle | en_US |
dc.contributor.author | Barrios, Carlos H. | en_US |
dc.contributor.author | Somali, Isil | en_US |
dc.contributor.author | Smichkoska, Snezhana | en_US |
dc.contributor.author | Martinez, Noelia | en_US |
dc.contributor.author | Alonso, Mirta Garcia | en_US |
dc.contributor.author | Link, John S. | en_US |
dc.contributor.author | Mayer, Ingrid A. | en_US |
dc.contributor.author | Cold, Søren | en_US |
dc.contributor.author | Murillo, Serafin Morales | en_US |
dc.contributor.author | Senecal, Francis | en_US |
dc.contributor.author | Inoue, Kenichi | en_US |
dc.contributor.author | Ruiz-Borrego, Manuel | en_US |
dc.contributor.author | Hui, Rina | en_US |
dc.contributor.author | Denduliri, Neelima | en_US |
dc.contributor.author | Patt, Debra | en_US |
dc.contributor.author | Rugo, Hope S. | en_US |
dc.contributor.author | Johnston, Stephen R.D. | en_US |
dc.contributor.author | Bryce, Richard | en_US |
dc.contributor.author | Zhang, Bo | en_US |
dc.contributor.author | Xu, Feng | en_US |
dc.contributor.author | Wong, Alvin | en_US |
dc.contributor.author | Martin, Miguel | en_US |
dc.date.accessioned | 2020-10-29T11:13:07Z | - |
dc.date.available | 2020-10-29T11:13:07Z | - |
dc.date.issued | 2020-10 | - |
dc.identifier.uri | http://hdl.handle.net/20.500.12188/9446 | - |
dc.language.iso | en | en_US |
dc.publisher | Elsevier BV | en_US |
dc.relation.ispartof | Clinical Breast Cancer | en_US |
dc.title | Final efficacy results of neratinib in HER2-positive hormone receptor-positive early-stage breast cancer from the phase III ExteNET trial | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1016/j.clbc.2020.09.014 | - |
dc.identifier.url | https://www.clinical-breast-cancer.com/article/S1526-8209(20)30258-5/fulltext | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
crisitem.author.dept | Faculty of Medicine | - |
Appears in Collections: | Faculty of Medicine: Journal Articles |
Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.